Polycystic ovary syndrome (PCOS) affects 8–13% of women of reproductive age and is deeply intertwined with insulin resistance and obesity. GLP-1 medications address the core metabolic dysfunction of PCOS directly.
Insulin resistance in PCOS causes hyperinsulinemia, which stimulates ovarian androgen production (causing irregular periods, acne, excess hair). Weight gain worsens insulin resistance, closing a vicious cycle. GLP-1 breaks this cycle at multiple points.
Multiple trials show GLP-1 medications outperform metformin for weight loss in PCOS. A 2024 meta-analysis found semaglutide produced significantly better improvements in BMI, testosterone levels, and menstrual regularity compared to other treatments.
Improved ovulation means increased fertility — an important consideration. GLP-1 should be stopped before trying to conceive and during pregnancy. Discuss contraception with your doctor when starting GLP-1 for PCOS.
As androgen levels normalize with weight loss on GLP-1, many PCOS patients report improvement in acne and unwanted hair growth — though this typically takes 6–12 months to become visible.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.